endocrine therapy

Related by string. Endocrine Therapy * Endocrine : endocrine disrupting compounds . endocrine disrupting chemicals . endocrine disruption . endocrine disrupting . endocrine disrupter . Endocrine Disruption Exchange / Therapy . THERAPY : stem cell therapy . Hormone Replacement Therapy . cognitive behavioral therapy . active antiretroviral therapy . gene therapy * adjuvant endocrine therapy *

Related by context. Frequent words. (Click for all words.) 64 adjuvant therapy 63 trastuzumab 62 metastatic renal cell carcinoma 61 chemoradiation 60 prognostic factors 60 gefitinib 60 cetuximab 59 HER2 positive 59 anastrozole 59 hormone receptor positive 59 imatinib 58 azacitidine 58 belinostat 58 anthracyclines 58 liver metastases 58 bone metastasis 58 adjuvant chemotherapy 58 cisplatin 58 sunitinib 58 bortezomib 58 docetaxel 58 castration resistant prostate cancer 58 phenoxodiol 57 vandetanib 57 tumor recurrence 57 HGS ETR1 57 chemotherapy regimens 57 CoFactor 57 chemotherapeutic agent 57 zoledronic acid 57 hormonal therapy 57 HER2 positive breast cancer 57 letrozole 56 erlotinib 56 peginterferon 56 vinorelbine 56 HRPC 56 pemetrexed 56 exemestane 56 antiplatelet therapy 56 metastatic prostate cancer 56 hypercalcemia 56 nilotinib 56 relapsing remitting multiple sclerosis 56 doxorubicin 56 rituximab 56 aromatase inhibitor 56 bevacizumab 56 median PFS 56 chemotherapeutics 55 gemcitabine 55 bone metastases 55 refractory multiple myeloma 55 adalimumab 55 taxanes 55 chemotherapy regimen 55 NSCLC 55 dasatinib 55 resistant ovarian cancer 55 Femara 55 metastatic colorectal cancer 55 brain metastases 55 estrogen receptor positive 55 cardiovascular morbidity 55 tamoxifen 55 interferon beta 1a 55 breast cancer recurrence 54 chemotherapeutic agents 54 FOLFOX 54 estrogen receptor 54 GRN#L 54 VIDAZA 54 tumor shrinkage 54 BAY #-# 54 LMWH 54 sorafenib 54 biologic therapy 54 pralatrexate 54 chronic lymphocytic leukemia CLL 54 cancer therapeutics 54 Bevacizumab 54 temozolomide 54 HER2 54 metastases 54 antitumor activity 54 evaluable patients 54 metastatic breast cancer 54 topotecan 54 panitumumab 53 kinase inhibitors 53 XYOTAX 53 myelosuppression 53 chemotherapies 53 myelodysplastic syndromes MDS 53 taxane 53 Torisel 53 ASA# 53 adenoma 53 unresectable 53 anthracycline 53 Cisplatin

Back to home page